Condensed Consolidated Statements of Equity (Unaudited) - USD ($)	Boyalife Investment Fund II, Inc. [Member] Common Stock [Member]	Boyalife Investment Fund II, Inc. [Member] Additional Paid-in Capital [Member]	Boyalife Investment Fund II, Inc. [Member] Retained Earnings [Member]	Boyalife Investment Fund II, Inc. [Member] AOCI Attributable to Parent [Member]	[1]	Boyalife Investment Fund II, Inc. [Member] Noncontrolling Interest [Member]	Boyalife Investment Fund II, Inc. [Member]	Registered Direct Offering [Member] Common Stock [Member]	Registered Direct Offering [Member] Additional Paid-in Capital [Member]	Registered Direct Offering [Member] Retained Earnings [Member]	Registered Direct Offering [Member] AOCI Attributable to Parent [Member]	[1]	Registered Direct Offering [Member] Noncontrolling Interest [Member]	Registered Direct Offering [Member]	At The Market Offering Agreement [Member] Common Stock [Member]	At The Market Offering Agreement [Member] Additional Paid-in Capital [Member]	At The Market Offering Agreement [Member] Retained Earnings [Member]	At The Market Offering Agreement [Member] AOCI Attributable to Parent [Member]	[1]	At The Market Offering Agreement [Member] Noncontrolling Interest [Member]	At The Market Offering Agreement [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	[1]	Noncontrolling Interest [Member]	Total
Balance (in shares) at Dec. 31, 2018																						2,168,337
Balance at Dec. 31, 2018																						$ 2,000	$ 235,888,000	$ (227,435,000)	$ (13,000)		$ (1,711,000)	$ 6,731,000
Stock-based compensation expense																							81,000					81,000
Exercise of pre-funded warrants (in shares)																						50,000
Exercise of pre-funded warrants																							5,000					5,000
Discount due to beneficial conversion features																							1,513,000					1,513,000
Foreign currency translation gain (loss)																									(4,000)			(4,000)
Net loss																								(1,871,000)			(176,000)	(2,047,000)
Reorganization of subsidiary and related change in non-controlling interest																							(2,843,000)				2,843,000
Balance (in shares) at Mar. 31, 2019																						2,218,337
Balance at Mar. 31, 2019																						$ 2,000	234,644,000	(229,306,000)	(17,000)		956,000	6,279,000
Balance (in shares) at Dec. 31, 2019																						2,843,601
Balance at Dec. 31, 2019																						$ 3,000	237,313,000	(236,932,000)	2,000		530,000	916,000
Stock-based compensation expense																							67,000					67,000
Exercise of pre-funded warrants (in shares)																						100,000
Exercise of pre-funded warrants																							10,000					10,000
Exercise of warrants (in shares)																						7,866
Exercise of warrants																							47,000					47,000
Discount due to beneficial conversion features																							1,869,000					1,869,000
Conversion of note payable to common stock (in shares)	1,666,670																					100,000
Conversion of note payable to common stock	$ 2,000	$ 2,998,000					$ 3,000,000																180,000					180,000
Issuance of common stock (in shares)								1,000,002							50,746						50,746
Issuance of common stock								$ 1,000	$ 3,106,000					$ 3,107,000		$ 114,000					$ 114,000
Foreign currency translation gain (loss)																									38,000			38,000
Net loss																								(4,602,000)			(141,000)	(4,743,000)
Balance (in shares) at Mar. 31, 2020																						5,768,885
Balance at Mar. 31, 2020																						$ 6,000	$ 245,704,000	$ (241,534,000)	$ 40,000		$ 389,000	$ 4,605,000

[1] Accumulated other comprehensive loss.